Skip to main content
PMC home page
Journal of Virology logoLink to Journal of Virology
. 1993 Dec;67(12):7017–7024. doi: 10.1128/jvi.67.12.7017-7024.1993

Aleutian mink disease parvovirus infection of mink macrophages and human macrophage cell line U937: demonstration of antibody-dependent enhancement of infection.

H Kanno 1, J B Wolfinbarger 1, M E Bloom 1
PMCID: PMC238162  PMID: 8230426

Abstract

Aleutian mink disease parvovirus (ADV) infects macrophages in adult mink. The virulent ADV-Utah I strain, but not the cell culture-adapted ADV-G strain, infects mink peritoneal macrophage cultures and the human macrophage cell line U937 in vitro. However, preincubation of ADV-G with ADV-infected mink serum enhanced its infectivity for U937 cells. the enhancing activity was present in the protein A-binding immunoglobulin G fraction in the serum, but F(ab')2 fragments failed to enhance the infection. On the other hand, the same sera inhibited ADV-G infection of Crandell feline kidney (CRFK) cells. Although U937 cells were not fully permissive for antibody-enhanced ADV-G infection, ADV mRNA expression, genome amplification, and protein expression were identical to those found previously for ADV-Utah I infection of U937 cells. Preincubation of ADV-Utah I with soluble protein A partly inhibited the infection of U937 cells but did not affect infection of CRFK cells. In mink peritoneal macrophages, preincubation with the infected mink serum did not make ADV-G infectious. However, the infectivity for mink macrophages of antibody-free ADV-Utah I prepared from the lungs of infected newborn mink kits was enhanced by ADV-infected mink serum. Moreover, protein A partly blocked ADV-Utah I infection of mink macrophage cultures. These results suggested that ADV-Utah I enters mink macrophages and U937 cells via an Fc receptor-mediated mechanism. This mechanism, antibody-dependent enhancement, may also contribute to ADV infection in vivo. Furthermore, since ADV infection in mink is characterized by overproduction of anti-ADV immunoglobulins, antibody-dependent enhancement may play a critical role in the establishment of persistent infection with ADV in vivo.

Full text

PDF
7021

Images in this article

7019Image
on p.7019
7021Image
on p.7021

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aasted B., Race R. E., Bloom M. E. Aleutian disease virus, a parvovirus, is proteolytically degraded during in vivo infection in mink. J Virol. 1984 Jul;51(1):7–13. doi: 10.1128/jvi.51.1.7-13.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Alexandersen S., Bloom M. E., Perryman S. Detailed transcription map of Aleutian mink disease parvovirus. J Virol. 1988 Oct;62(10):3684–3694. doi: 10.1128/jvi.62.10.3684-3694.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Alexandersen S., Bloom M. E. Studies on the sequential development of acute interstitial pneumonia caused by Aleutian disease virus in mink kits. J Virol. 1987 Jan;61(1):81–86. doi: 10.1128/jvi.61.1.81-86.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Alexandersen S., Bloom M. E., Wolfinbarger J. Evidence of restricted viral replication in adult mink infected with Aleutian disease of mink parvovirus. J Virol. 1988 May;62(5):1495–1507. doi: 10.1128/jvi.62.5.1495-1507.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Alexandersen S., Bloom M. E., Wolfinbarger J., Race R. E. In situ molecular hybridization for detection of Aleutian mink disease parvovirus DNA by using strand-specific probes: identification of target cells for viral replication in cell cultures and in mink kits with virus-induced interstitial pneumonia. J Virol. 1987 Aug;61(8):2407–2419. doi: 10.1128/jvi.61.8.2407-2419.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Alexandersen S., Hau J. Rocket line immunoelectrophoresis: an improved assay for simultaneous quantification of a mink parvovirus (Aleutian disease virus) antigen and antibody. J Virol Methods. 1985 Feb;10(2):145–151. doi: 10.1016/0166-0934(85)90100-4. [DOI] [PubMed] [Google Scholar]
  7. Alexandersen S., Larsen S., Cohn A., Uttenthal A., Race R. E., Aasted B., Hansen M., Bloom M. E. Passive transfer of antiviral antibodies restricts replication of Aleutian mink disease parvovirus in vivo. J Virol. 1989 Jan;63(1):9–17. doi: 10.1128/jvi.63.1.9-17.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Ananaba G. A., Anderson L. J. Antibody enhancement of respiratory syncytial virus stimulation of leukotriene production by a macrophagelike cell line. J Virol. 1991 Sep;65(9):5052–5060. doi: 10.1128/jvi.65.9.5052-5060.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Anderson C. L., Abraham G. N. Characterization of the Fc receptor for IgG on a human macrophage cell line, U937. J Immunol. 1980 Dec;125(6):2735–2741. [PubMed] [Google Scholar]
  10. Bloom M. E. Aleutian disease of mink: production of 14C-labeled antiviral antibodies by mink lymphoid cells in vitro. Infect Immun. 1976 Jan;13(1):281–283. doi: 10.1128/iai.13.1.281-283.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Bloom M. E., Kaaden O. R., Huggans E., Cohn A., Wolfinbarger J. B. Molecular comparisons of in vivo- and in vitro-derived strains of Aleutian disease of mink parvovirus. J Virol. 1988 Jan;62(1):132–138. doi: 10.1128/jvi.62.1.132-138.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Bloom M. E., Mayer L. W., Garon C. F. Characterization of the Aleutian disease virus genome and its intracellular forms. J Virol. 1983 Mar;45(3):977–984. doi: 10.1128/jvi.45.3.977-984.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Bloom M. E., Race R. E., Hadlow W. J., Chesebro B. Aleutian disease of mink: the antibody response of sapphire and pastel mink to Aleutian disease virus. J Immunol. 1975 Oct;115(4):1034–1037. [PubMed] [Google Scholar]
  14. Bloom M. E., Race R. E., Wolfinbarger J. B. Analysis of Aleutian disease of mink parvovirus infection using strand-specific hybridization probes. Intervirology. 1987;27(2):102–111. doi: 10.1159/000149727. [DOI] [PubMed] [Google Scholar]
  15. Cafruny W. A., Plagemann P. G. Immune response to lactate dehydrogenase-elevating virus: isolation of infectious virus-immunoglobulin G complexes and quantitation of specific antiviral immunoglobulin G response in wild-type and nude mice. Infect Immun. 1982 Sep;37(3):1001–1006. doi: 10.1128/iai.37.3.1001-1006.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Cafruny W. A., Plagemann P. G. Immune response to lactate dehydrogenase-elevating virus: serologically specific rabbit neutralizing antibody to the virus. Infect Immun. 1982 Sep;37(3):1007–1012. doi: 10.1128/iai.37.3.1007-1012.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Chesebro B., Bloom M., Hadlow W., Race R. Purification and ultrastructure of Aleutian disease virus of mink. Nature. 1975 Apr 3;254(5499):456–457. doi: 10.1038/254456a0. [DOI] [PubMed] [Google Scholar]
  18. Coe J. E., Hadlow W. J. Studies on immunoglobulins of mink: definition of IgG, IgA and IgM. J Immunol. 1972 Feb;108(2):530–537. [PubMed] [Google Scholar]
  19. Crandell R. A., Fabricant C. G., Nelson-Rees W. A. Development, characterization, and viral susceptibility of a feline (Felis catus) renal cell line (CRFK). In Vitro. 1973 Nov-Dec;9(3):176–185. doi: 10.1007/BF02618435. [DOI] [PubMed] [Google Scholar]
  20. Gollins S. W., Porterfield J. S. A new mechanism for the neutralization of enveloped viruses by antiviral antibody. Nature. 1986 May 15;321(6067):244–246. doi: 10.1038/321244a0. [DOI] [PubMed] [Google Scholar]
  21. Halstead S. B., O'Rourke E. J. Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody. J Exp Med. 1977 Jul 1;146(1):201–217. doi: 10.1084/jem.146.1.201. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Hanson D. C., Schumaker V. N. A model for the formation and interconversion of protein A-immunoglobulin G soluble complexes. J Immunol. 1984 Mar;132(3):1397–1409. [PubMed] [Google Scholar]
  23. Kanno H., Wolfinbarger J. B., Bloom M. E. Aleutian mink disease parvovirus infection of mink peritoneal macrophages and human macrophage cell lines. J Virol. 1993 Apr;67(4):2075–2082. doi: 10.1128/jvi.67.4.2075-2082.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Kanno H., Wolfinbarger J. B., Bloom M. E. Identification of Aleutian mink disease parvovirus transcripts in macrophages of infected adult mink. J Virol. 1992 Sep;66(9):5305–5312. doi: 10.1128/jvi.66.9.5305-5312.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Kontny U., Kurane I., Ennis F. A. Gamma interferon augments Fc gamma receptor-mediated dengue virus infection of human monocytic cells. J Virol. 1988 Nov;62(11):3928–3933. doi: 10.1128/jvi.62.11.3928-3933.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Krilov L. R., Anderson L. J., Marcoux L., Bonagura V. R., Wedgwood J. F. Antibody-mediated enhancement of respiratory syncytial virus infection in two monocyte/macrophage cell lines. J Infect Dis. 1989 Nov;160(5):777–782. doi: 10.1093/infdis/160.5.777. [DOI] [PubMed] [Google Scholar]
  27. Lodmell D. L., Bergman R. K., Bloom M. E., Ewalt L. C., Hadlow W. J., Race R. E. Impaired phagocytosis by the mononuclear phagocytic system in sapphire mink affected with Aleutian disease. Proc Soc Exp Biol Med. 1990 Oct;195(1):75–78. doi: 10.3181/00379727-195-43121. [DOI] [PubMed] [Google Scholar]
  28. Mady B. J., Erbe D. V., Kurane I., Fanger M. W., Ennis F. A. Antibody-dependent enhancement of dengue virus infection mediated by bispecific antibodies against cell surface molecules other than Fc gamma receptors. J Immunol. 1991 Nov 1;147(9):3139–3144. [PubMed] [Google Scholar]
  29. Moks T., Abrahmsén L., Nilsson B., Hellman U., Sjöquist J., Uhlén M. Staphylococcal protein A consists of five IgG-binding domains. Eur J Biochem. 1986 May 2;156(3):637–643. doi: 10.1111/j.1432-1033.1986.tb09625.x. [DOI] [PubMed] [Google Scholar]
  30. Mori S., Wolfinbarger J. B., Miyazawa M., Bloom M. E. Replication of Aleutian mink disease parvovirus in lymphoid tissues of adult mink: involvement of follicular dendritic cells and macrophages. J Virol. 1991 Feb;65(2):952–956. doi: 10.1128/jvi.65.2.952-956.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Ochiai H., Kurokawa M., Hayashi K., Niwayama S. Antibody-mediated growth of influenza A NWS virus in macrophagelike cell line P388D1. J Virol. 1988 Jan;62(1):20–26. doi: 10.1128/jvi.62.1.20-26.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Olsen C. W., Corapi W. V., Ngichabe C. K., Baines J. D., Scott F. W. Monoclonal antibodies to the spike protein of feline infectious peritonitis virus mediate antibody-dependent enhancement of infection of feline macrophages. J Virol. 1992 Feb;66(2):956–965. doi: 10.1128/jvi.66.2.956-965.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Porter D. D., Larsen A. E., Cox N. A., Porter H. G., Suffin S. C. Isolation of Aleutian disease virus of mink in cell culture. Intervirology. 1977;8(3):129–144. doi: 10.1159/000148888. [DOI] [PubMed] [Google Scholar]
  34. Porter D. D., Larsen A. E., Porter H. G. The pathogenesis of Aleutian disease of mink. I. In vivo viral replication and the host antibody response to viral antigen. J Exp Med. 1969 Sep 1;130(3):575–593. doi: 10.1084/jem.130.3.575. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Porterfield J. S. Antibody-dependent enhancement of viral infectivity. Adv Virus Res. 1986;31:335–355. doi: 10.1016/s0065-3527(08)60268-7. [DOI] [PubMed] [Google Scholar]
  36. Sjöquist J., Meloun B., Hjelm H. Protein A isolated from Staphylococcus aureus after digestion with lysostaphin. Eur J Biochem. 1972 Sep 25;29(3):572–578. doi: 10.1111/j.1432-1033.1972.tb02023.x. [DOI] [PubMed] [Google Scholar]
  37. Spalholz B. A., Tattersall P. Interaction of minute virus of mice with differentiated cells: strain-dependent target cell specificity is mediated by intracellular factors. J Virol. 1983 Jun;46(3):937–943. doi: 10.1128/jvi.46.3.937-943.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Stolze B., Kaaden O. R. Apparent lack of neutralizing antibodies in Aleutian disease is due to masking of antigenic sites by phospholipids. Virology. 1987 May;158(1):174–180. doi: 10.1016/0042-6822(87)90251-0. [DOI] [PubMed] [Google Scholar]
  39. Stueckemann J. A., Holth M., Swart W. J., Kowalchyk K., Smith M. S., Wolstenholme A. J., Cafruny W. A., Plagemann P. G. Replication of lactate dehydrogenase-elevating virus in macrophages. 2. Mechanism of persistent infection in mice and cell culture. J Gen Virol. 1982 Apr;59(Pt 2):263–272. doi: 10.1099/0022-1317-59-2-263. [DOI] [PubMed] [Google Scholar]
  40. Sundström C., Nilsson K. Establishment and characterization of a human histiocytic lymphoma cell line (U-937). Int J Cancer. 1976 May 15;17(5):565–577. doi: 10.1002/ijc.2910170504. [DOI] [PubMed] [Google Scholar]
  41. Tamura M., Webster R. G., Ennis F. A. Antibodies to HA and NA augment uptake of influenza A viruses into cells via Fc receptor entry. Virology. 1991 May;182(1):211–219. doi: 10.1016/0042-6822(91)90664-w. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES